Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment
Clinical Pharmacokinetics · 2025
DOI: 10.1007/s40262-024-01453-5 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Clinical Pharmacokinetics, 2025. Verfasst von Haeyoung Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, CA, 94404, USA. Hauptthemen laut MEDLINE: Adenosine Monophosphate, Alanine, Antiviral Agents, Renal Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Gilead Sciences, Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gilead Sciences, Inc., Foster City, CA, 94404, USA.
- Gilead Sciences, Inc., Foster City, CA, 94404, USA. eileen.kim8@gilead.com.
ORCID-Profile: Aryun Kim
Förderung
- Gilead Sciences, Inc
Zitieren
APA
Zhang, H., Humeniuk, R., Regan, S., Koullias, Y., Davies, S., John, A., Shen, G., Xiao, D., Hyland, R. H., Winter, H., & Kim, A. (2025). Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-024-01453-5
Vancouver
Zhang H, Humeniuk R, Regan S, Koullias Y, Davies S, John A, et al. Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment. Clinical Pharmacokinetics. 2025. doi:10.1007/s40262-024-01453-5
BibTeX
@article{Zhang2025,
author = {Zhang, Haeyoung and Humeniuk, Rita and Regan, Sean and Koullias, Yiannis and Davies, Santosh and John, Amy and Shen, Gong and Xiao, Deqing and Hyland, Robert H and Winter, Helen and Kim, Aryun},
title = {Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment},
journal = {Clinical Pharmacokinetics},
year = {2025},
doi = {10.1007/s40262-024-01453-5}
}
EUVIMED